0001104659-22-011061.txt : 20220202 0001104659-22-011061.hdr.sgml : 20220202 20220202215040 ACCESSION NUMBER: 0001104659-22-011061 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mashiach Nissim CENTRAL INDEX KEY: 0001357777 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37990 FILM NUMBER: 22586272 MAIL ADDRESS: STREET 1: C/O MACROCURE LTD. STREET 2: 25 HASIVIM STREET CITY: PETACH TIKVA STATE: L3 ZIP: 4959383 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LEAP THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001509745 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274412575 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 252 4343 MAIL ADDRESS: STREET 1: 47 THORNDIKE STREET STREET 2: SUITE B1-1 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Dekkun Corp DATE OF NAME CHANGE: 20110107 4 1 tm225302-12_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2022-01-31 0 0001509745 LEAP THERAPEUTICS, INC. LPTX 0001357777 Mashiach Nissim C/O LEAP THERAPEUTICS, INC. 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02141 1 0 0 0 Stock Option (Right to Buy) 1.94 2022-01-31 4 A 0 55000 0 A 2032-01-30 Common Stock 55000 55000 D The Option was granted pursuant to Leap's 2016 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of January 1, 2022, the Vesting Start Date. /s/ Douglas E. Onsi as attorney-in-fact for Nissim Mashiach 2022-02-02